IBT
RVNC

International Biotechnology Trust’s Revance Therapeutics, Inc. RVNC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$3.31M Hold
288,726
1.11% 25
2023
Q2
$7.3M Buy
288,726
+105,726
+58% +$2.67M 2.22% 15
2023
Q1
$5.89M Buy
183,000
+63,000
+53% +$2.03M 1.64% 22
2022
Q4
$2.21M Hold
120,000
0.68% 34
2022
Q3
$3.24M Buy
+120,000
New +$3.24M 1.04% 28